Professional
Added to YB: 2026-06-29
Pitch date: 2026-04-11
ABT [bullish]
Abbott Laboratories
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$163.9B
Pitch Price
N/A
Price Target
N/A
Dividend
2.68%
EV/EBITDA
15.77
P/E
26.36
EV/Sales
4.24
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
The Davenport Insider Buying Fund New Position: Abbott Laboratories
ABT (new position): Diversified healthcare (med devices, diagnostics, est. pharma, nutrition). Exact Sciences buy expands diagnostics TAM. Stock fell on weak Q4 (Nutrition -9% organic) but total organic +3.8% Q4/+5.5% yr; 2026 guided +6.5-7.5% on new launches. CEO bought $2M+, board member $1M+.
Read full article (1 min)